546 related articles for article (PubMed ID: 29372660)
1. Current challenges for cancer vaccine adjuvant development.
Bowen WS; Svrivastava AK; Batra L; Barsoumian H; Shirwan H
Expert Rev Vaccines; 2018 Mar; 17(3):207-215. PubMed ID: 29372660
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
[TBL] [Abstract][Full Text] [Related]
3. Cancer vaccines: between the idea and the reality.
Finn OJ
Nat Rev Immunol; 2003 Aug; 3(8):630-41. PubMed ID: 12974478
[TBL] [Abstract][Full Text] [Related]
4. Cancer immunotherapy: moving forward with peptide T cell vaccines.
Kumai T; Fan A; Harabuchi Y; Celis E
Curr Opin Immunol; 2017 Aug; 47():57-63. PubMed ID: 28734176
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific vaccines for cancer treatment.
Tagliamonte M; Petrizzo A; Tornesello ML; Buonaguro FM; Buonaguro L
Hum Vaccin Immunother; 2014; 10(11):3332-46. PubMed ID: 25483639
[TBL] [Abstract][Full Text] [Related]
6. At the bench: Engineering the next generation of cancer vaccines.
Shae D; Baljon JJ; Wehbe M; Becker KW; Sheehy TL; Wilson JT
J Leukoc Biol; 2020 Oct; 108(4):1435-1453. PubMed ID: 31430398
[TBL] [Abstract][Full Text] [Related]
7. Cancer vaccines: Targeting KRAS-driven cancers.
Zhang Y; Ma JA; Zhang HX; Jiang YN; Luo WH
Expert Rev Vaccines; 2020 Feb; 19(2):163-173. PubMed ID: 32174221
[No Abstract] [Full Text] [Related]
8. DNA vaccine for cancer immunotherapy.
Yang B; Jeang J; Yang A; Wu TC; Hung CF
Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
[TBL] [Abstract][Full Text] [Related]
9. Cancer Vaccines, Adjuvants, and Delivery Systems.
Paston SJ; Brentville VA; Symonds P; Durrant LG
Front Immunol; 2021; 12():627932. PubMed ID: 33859638
[TBL] [Abstract][Full Text] [Related]
10. Cancer vaccines.
Muehlbauer PM; Schwartzentruber DJ
Semin Oncol Nurs; 2003 Aug; 19(3):206-16. PubMed ID: 12962010
[TBL] [Abstract][Full Text] [Related]
11. Vaccines for established cancer: overcoming the challenges posed by immune evasion.
van der Burg SH; Arens R; Ossendorp F; van Hall T; Melief CJ
Nat Rev Cancer; 2016 Apr; 16(4):219-33. PubMed ID: 26965076
[TBL] [Abstract][Full Text] [Related]
12. SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines.
Sharma RK; Yolcu ES; Shirwan H
Expert Rev Vaccines; 2014 Mar; 13(3):387-98. PubMed ID: 24521311
[TBL] [Abstract][Full Text] [Related]
13. Use of adjuvants for immunotherapy.
Circelli L; Tornesello M; Buonaguro FM; Buonaguro L
Hum Vaccin Immunother; 2017 Aug; 13(8):1774-1777. PubMed ID: 28604160
[TBL] [Abstract][Full Text] [Related]
14. Cancer vaccine adjuvants--recent clinical progress and future perspectives.
Banday AH; Jeelani S; Hruby VJ
Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):1-11. PubMed ID: 25318595
[TBL] [Abstract][Full Text] [Related]
15. The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification.
Jou J; Harrington KJ; Zocca MB; Ehrnrooth E; Cohen EEW
Clin Cancer Res; 2021 Feb; 27(3):689-703. PubMed ID: 33122346
[TBL] [Abstract][Full Text] [Related]
16. Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer.
Arens R; van Hall T; van der Burg SH; Ossendorp F; Melief CJ
Semin Immunol; 2013 Apr; 25(2):182-90. PubMed ID: 23706598
[TBL] [Abstract][Full Text] [Related]
17. A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.
Song C; Zheng XJ; Liu CC; Zhou Y; Ye XS
Oncotarget; 2017 Jul; 8(29):47330-47343. PubMed ID: 28537884
[TBL] [Abstract][Full Text] [Related]
18. Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.
Curigliano G; Criscitiello C; Esposito A; Fumagalli L; Gelao L; Locatelli M; Minchella I; Goldhirsch A
Breast; 2013 Aug; 22 Suppl 2():S96-9. PubMed ID: 24074802
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Vaccines for Cancer Immunotherapy.
Wang J; Mamuti M; Wang H
ACS Biomater Sci Eng; 2020 Nov; 6(11):6036-6052. PubMed ID: 33449675
[TBL] [Abstract][Full Text] [Related]
20. [Development of Nucleic Acid-Based Adjuvant for Cancer Immunotherapy].
Kobiyama K; Ishii KJ
Gan To Kagaku Ryoho; 2015 Sep; 42(9):1040-5. PubMed ID: 26469159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
